newsfilter
← Latest News
GlobeNewswire·

Entera Announces Third Quarter 2026 Financial Results and Business Updates

Clinical Preparations Advanced for EB613 Phase 3 Osteoporosis Study, with First Site Activation Expected in Late 2026 Clinical and Commercial Leadership Expanded with Appointment of Senior Executives and Directors